Phosphate removal and hemodialysis conditions. Hyperphosphatemia is frequently found in hemodialysis patients, and the association with an increased risk of mortality has been demonstrated. Other authors have linked hyperphosphatemia to increased cardiovascular mortality. The normalization of phosphate plasma levels is therefore an important goal in the treatment of end-stage renal disease patients. Absorption of phosphate from the food exceeds the elimination through a hemodialysis treatment, and this leads to a chronic phosphate load for the majority of hemodialysis patients. This imbalance should be improved by either a reduction of phosphate absorption or an increased removal of phosphate. A reduction of phosphate absorption can be achi...
Patients with advanced chronic kidney disease have an inability to excrete phosphorus normally leadi...
Poor control of mineral metabolism is independently associated with mortality in patients receiving ...
An introduction to phosphate binders for the treatment of hyperphosphatemia in patients with chronic...
Phosphate removal and hemodialysis conditions. Hyperphosphatemia is frequently found in hemodialysis...
Background. Half of the dialysis population suffers from hyperphosphataemia, which is now recognized...
Prevention and correction of hyperphosphatemia is a major goal of chronic kidney disease-mineral and...
Background: An abnormal serum phosphate concentration is common in acute renal failure patients, wit...
Hyperphosphatemia occurs universally in end-stage renal disease (ESRD) unless efforts are made to pr...
The role of daily dialysis in the control of hyperphosphatemia.In patients with end-stage renal dise...
Calcium and phosphate changes, besides their involvement in bone disease, have been claimed to also ...
Phosphate kinetics during hemodialysis: Evidence for biphasic regulation.BackgroundHyperphosphatemia...
The inadequacy of dialysis and hyperphosphatemia are both associated with morbidity and mortality in...
Approximately 8-10% of the adult population in Europe suffers from kidney diseases. Cardiovascular c...
Hyperphosphatemia is an independent predictor of mor-tality in end-stage renal disease patients, and...
Abstract Introduction. It is largely agreed that preservation of residual kidney function (RKF) has ...
Patients with advanced chronic kidney disease have an inability to excrete phosphorus normally leadi...
Poor control of mineral metabolism is independently associated with mortality in patients receiving ...
An introduction to phosphate binders for the treatment of hyperphosphatemia in patients with chronic...
Phosphate removal and hemodialysis conditions. Hyperphosphatemia is frequently found in hemodialysis...
Background. Half of the dialysis population suffers from hyperphosphataemia, which is now recognized...
Prevention and correction of hyperphosphatemia is a major goal of chronic kidney disease-mineral and...
Background: An abnormal serum phosphate concentration is common in acute renal failure patients, wit...
Hyperphosphatemia occurs universally in end-stage renal disease (ESRD) unless efforts are made to pr...
The role of daily dialysis in the control of hyperphosphatemia.In patients with end-stage renal dise...
Calcium and phosphate changes, besides their involvement in bone disease, have been claimed to also ...
Phosphate kinetics during hemodialysis: Evidence for biphasic regulation.BackgroundHyperphosphatemia...
The inadequacy of dialysis and hyperphosphatemia are both associated with morbidity and mortality in...
Approximately 8-10% of the adult population in Europe suffers from kidney diseases. Cardiovascular c...
Hyperphosphatemia is an independent predictor of mor-tality in end-stage renal disease patients, and...
Abstract Introduction. It is largely agreed that preservation of residual kidney function (RKF) has ...
Patients with advanced chronic kidney disease have an inability to excrete phosphorus normally leadi...
Poor control of mineral metabolism is independently associated with mortality in patients receiving ...
An introduction to phosphate binders for the treatment of hyperphosphatemia in patients with chronic...